Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS

The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)

NCT05922995 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects

NCT06323655 ·Status: COMPLETED ·Phase: PHASE1

Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception

NCT01429116 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant

NCT06701396 ·Status: RECRUITING ·Phase: PHASE3

Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

NCT05361707 ·Status: RECRUITING ·Phase: PHASE3

An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia

NCT03338764 ·Status: WITHDRAWN ·Phase: PHASE3

Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia

NCT00755495 ·Status: COMPLETED ·Phase: PHASE2

SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.

NCT03331042 ·Status: COMPLETED ·Phase: PHASE3

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

NCT01430754 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

NCT06953869 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia

NCT03771664 ·Status: TERMINATED ·Phase: PHASE3

Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic

NCT02818569 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy of Ramelteon in Healthy Subjects

NCT00671190 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Tolerability of Tasipimidine in Sleepless Patients

NCT06956495 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception

NCT01218789 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Role of the Catechol-O-methyltransferase (COMT) in the Physiological Regulation of Vigilance

NCT02080715 ·Status: COMPLETED ·Phase: PHASE1

A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

NCT02512588 ·Status: COMPLETED ·Phase: PHASE2

A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia

NCT03542851 ·Status: UNKNOWN ·Phase: PHASE2

Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia

NCT00280423 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model

NCT03284931 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder

NCT05525637 ·Status: RECRUITING ·Phase: PHASE3

Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia

NCT00280436 ·Status: COMPLETED ·Phase: PHASE2

Tizanidine vs. Zolpidem in Primary Insomnia: A Randomized Trial

NCT06303076 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Melatonin Treatment for Induced Transient Insomnia

NCT00950885 ·Status: COMPLETED ·Phase: NA

Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers

NCT00716521 ·Status: COMPLETED ·Phase: PHASE1